ClinicalTrials.gov research-record information
ClinicalTrials.gov research records
Snapshot scope: This page is a static ClinicalTrials.gov research-record snapshot retrieved on . The fixed source query returned 13 results; after an exact city/state check of listed facilities, 12 records were retained for Birmingham, Alabama. It is not a clinic, enrollment, or local-availability directory.
Records are retained only after the listed facility location matches the fixed city and state. This location match does not establish enrollment, site activity, eligibility, or local availability.
How to read this snapshot
All retained records
The counts below summarize every retained record in this snapshot. They describe registry study status only, not whether a particular facility is enrolling.
Records in this snapshot
The retrieved source snapshot contains 12 exact-location records and 10 listed facilities. All 12 retained records are shown below.
Registry title: A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Registry title: MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial
Registry title: A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Registry title: A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Registry title: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Registry title: Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Registry title: A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
Registry title: REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
Registry title: A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
Registry title: Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
Registry title: Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
Registry title: A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
Source retrieval and snapshot limits
At retrieval, the fixed ClinicalTrials.gov source query returned 13 results. After an exact city/state check of listed facilities, 12 records were retained for Birmingham, Alabama, across 10 listed facilities. All 12 retained records are shown on this page.
Live search scope: This broader live search does not reproduce the included-status filter used for this snapshot, so it can show other study statuses and change after source retrieval.
Snapshot limits: The retrieval timestamp records when Why Peptides retrieved the ClinicalTrials.gov source query; it is not an independent validation. Record update dates are supplied by ClinicalTrials.gov and can differ from the retrieval timestamp. This static snapshot is not a complete or live catalog and can become stale. Why Peptides has not independently validated record details, facilities, enrollment, contacts, eligibility, or site status. For a displayed study, open its linked ClinicalTrials.gov NCT record for current contacts, eligibility, and site status.